Lantheus Holdings, Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Lantheus Holdings, Inc. (LNTH) holds an ST Score of 55.1 out of 100 (B-), with its strongest factor being Sentiment (A+) and its weakest Valuation (F). Analysts rate LNTH Buy across 19 ratings with a $104.48 average price target (+0.0% vs the current $100.55).
- Strongest
- SentimentA+
- Weakest
- ValuationF
All factor grades
- SentimentA+
- ProfitabilityA
- MomentumB+
- Financial StrengthC+
- GrowthC+
- ForecastC-
- ValuationF
- Piotroski5/9
Contact
LNTH stock: frequently asked questions
What is LNTH's ST Score?
Lantheus Holdings, Inc. (LNTH) has an ST Score of 55.1 out of 100, an overall grade of B-. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is LNTH a buy, sell, or hold?
Wall Street's consensus rating on LNTH is Buy based on 19 analyst ratings. Our own ST Score grades it B- (55.1/100). This is data, not investment advice — always do your own research.
What is LNTH's valuation grade?
Lantheus Holdings, Inc. (LNTH) earns a valuation grade of F, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is LNTH's growth grade?
Lantheus Holdings, Inc. (LNTH) earns a growth grade of C+, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is LNTH's profitability grade?
Lantheus Holdings, Inc. (LNTH) earns a profitability grade of A, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is LNTH's financial strength grade?
Lantheus Holdings, Inc. (LNTH) earns a financial strength grade of C+, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for LNTH?
The average analyst price target for Lantheus Holdings, Inc. (LNTH) is $104.48 from 19 analysts, which is +0.0% versus the recent price of $100.55.
What is LNTH's Piotroski score?
Lantheus Holdings, Inc. (LNTH) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.